Companies › ACHV

Achieve Life Sciences Inc (ACHV)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000949858 · EDGAR filings · Updated 2026-07-28

Achieve Life Sciences Inc (ACHV) has reported institutional ownership of 40.4%, with 81 institutional managers holding positions valued at $63.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-28 — SCHEDULE 13G/A filed
• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-08 — SCHEDULE 13G filed
• 2026-07-06 — Current report (8-K) filed
• 2026-06-08 — ARS filed
• 2026-06-08 — Proxy statement (DEF 14A) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Achieve Life Sciences Inc has 81 institutional holders and institutional ownership of 40.4%.

Insider activity

Insiders reported 12 transactions (0 buys, 6 sells) across 9 reporting insiders, with a net reported value of −$1.08M.

Data flags from SEC filings

Related companies

Unicycive Therapeutics Inc (UNCY) · LIFEMD (LFMD) · HUTCHMED CHINA LTD (HCM) · ALDEYRA THERAPEUTICS INC (ALDX) · Pliant Therapeutics Inc (PLRX) · AVITA MEDICAL INC (RCEL)